Further mechanistic insights suggest that AKT negatively regulates myogenic gene expression through its interaction with PAX3-FOXO1, thereby contributing to the differentiation blockade characteristic of ARMS [334]. The gene discussed is FOXO1; the disease is alveolar rhabdomyosarcoma.